METHOD FOR PREVENTING RESPIRATORY COMPLICATIONS IN PATIENTS AFTER ACCOMPANY VARTILE SURGICAL TREATMENT OF LUNG CANCER Russian patent published in 2019 - IPC A61B17/04 A61B1/267 A61M5/142 A61M15/00 A61M25/01 A61K31/65 A61K31/167 A61K31/46 A61K31/545 A61K31/7004 A61K38/46 A61P11/00 A61P41/00 A61M16/04 A61H1/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for prevention of respiratory complications in patients after surgical treatment of lung cancer. That is ensured three days before surgery by a nebuliser therapy with daily inhalations of a mixture of solutions of cellulose 1 ml, berodual – 1 ml and saline solution 0.9 % – 2 ml, which is performed daily, three times per day for 10 minutes. An hour before the surgery, the patient is catheterized by the epidural space at level Th 4–5; intravenously administered daily dose of broad-spectrum antibiotic. During the operation, after the main stage, to the patient on the side of the pleural cavity in the rib-vertebral articulation and the sternocostal area at the level of the thoracotomy, as well as above and below located between the intercostal space, lymphotropic mixture of preparations containing naropin 0.2 % – 20 ml, lydase 32 action units, 5 ml 5 % glucose solution, ceftriaxone 1.0 mg is administered. In the early postoperative period immediately after extubation, a sanation fibrobronchoscopy is performed. In the postoperative period, naropin 0.2 % solution is introduced through an epidural catheter through the infusion pump for 48 hours at rate of 2–4 ml/h. From the first postoperative day, the nebuliser therapy is continued; patient is activated one day after operation.

EFFECT: method provides reducing the risk of developing respiratory disorders and favorable outcome of surgical treatment due to complex effect on causative factors playing a role in the development of perioperative complications.

1 cl, 1 ex